Home/Filings/4/0001209191-19-052722
4//SEC Filing

Hogenhuis Wladimir 4

Accession 0001209191-19-052722

CIK 0001515673other

Filed

Oct 6, 8:00 PM ET

Accepted

Oct 7, 7:40 PM ET

Size

4.9 KB

Accession

0001209191-19-052722

Insider Transaction Report

Form 4
Period: 2019-10-04
Hogenhuis Wladimir
Chief Operating Officer
Transactions
  • Tax Payment

    Common Stock

    2019-10-04$44.52/sh1,297$57,74218,703 total
Footnotes (2)
  • [F1]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
  • [F2]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Issuer

Ultragenyx Pharmaceutical Inc.

CIK 0001515673

Entity typeother

Related Parties

1
  • filerCIK 0001755074

Filing Metadata

Form type
4
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 7:40 PM ET
Size
4.9 KB